EP3193932
ANTIBODY FORMULATIONS
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
15.9.2015EP published:
25.5.2022EP application number:
15772124.2
EPO information:
European Patent Register
Max expiry date:
14.9.2035
Title in English:
ANTIBODY FORMULATIONSLanguage of the patent:
English
Timeline
Today
15.9.2015EP application
25.5.2022EP Publication
Owner
Name:
F. Hoffmann-La Roche AGAddress:
Grenzacherstrasse 124, 4070 Basel, CH
Inventor
Name:
LE, LanAddress:
South San Francisco, CA 94080-4990, US
Name:
CONNOLLY, BrianAddress:
South San Francisco, CA 94080-4990, US
Priority
Number:
201462050739 PDate:
15.9.2014Country:
US
Classification
Categories:
A61K 39/395, C07K 16/22